Health
Neuroprotectant delivered to brain in nanoparticles may improve stroke treatment, outcomes – EurekAlert
Encapsulating a neuroprotective agent in nanoparticles resulted in targeted delivery of the treatment to brain cells deprived of oxygen by a stroke.
In a mouse…
DALLAS, March 11, 2021 — When NA1, a neuroprotectant, was delivered to the brain in nanoparticles, it reduced stroke severity and improved survival in a mouse model of stroke, according to preliminary research to be presented at the American Stroke Association’s International Stroke Conference 2021. The virtual meeting is March 17-19, 2021 and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
In an earlier human trial (the ESCAPE-NA1…
-
Business17 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News17 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business21 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business20 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025